Corrie Painter: Come join us poster side at ASCO2024
Corrie Painter, Strategic Advisor at Broad Institute of MIT and Harvard, shared a post by Precede Biosciences on LinkedIn, adding:
”Come join us poster side at ASCO2024. We are building tools to rapidly and effectively identify the right patients for the right therapies through a liquid/epigenomics approach.
At ASCO, we will be highlighting work developing tests that inform on the activation status of the estrogen receptor signaling pathway AND work developing a HER2 test across cancer, all from 1 ml of plasma.”
Quoting Precede Biosciences’s post:
”ASCO24 abstracts are now available. Check out Precede Biosciences’ exciting new scientific presentations for our comprehensive epigenomic Liquid Biopsy platform. View abstracts 3047 and 1066.”
Source: Corrie Painter/LinkedIn and Precede Biosciences/LinkedIn